The Efficacy of Saxenda in Weight Management: A Comprehensive Analysis - PERGAMIGOS
According to numerous clinical trials and studies, Saxenda is effective in helping individuals lose weight when used with healthy diet and regular exercise. It has been proven to lead to change.
Professional authorities on the efficacy of Saxenda
According to a 2015 study published in New England Journal of Medicine, Saxenda's effects were investigated in a random and double-blind placebo control test containing more than 3,500 participants with obesity. The study shows that those who received SAXENDA showed 56 weeks laterI lost 4.5% more than placebo.
In another 2017 study published in Lancet, researchers helped Saxenda to achieve more than 5% weight loss by patients with obesity or overweight, which is considered a clinically significant amount in long-term weight management.
Asmbs (American Society of Metabolic & Bariatric Surgeons) say that GLP-1 receptor agents such as Saxenda are effective in inducing practical and sustained weight loss when used with lifestyle interventions.
According to the National Health and Care Excellence (NICE), Saxenda is recommended as a cost-effective treatment option for adults with at least one weight-related diseases.
In 2020, the US Food and Drug Administration (FDA) proved its effect as a weight management tool across other ages by using the approval of Saxenda of children aged 12-17 as BMI in overweight.
Mechanism of Action and Efficacy of Saxenda in Weight Management
SAXENDA acts by mimicking the action of GLP-1, a hormone released from the intestines in response to food consumption. GLP-1 includes some physiological effects, including insulin secretion, glucagon secretion, stomach discharge slowdown and appetite reduction. It has the action mechanism of SAXENDA, which binds and activates GLP-1 receptors in pancreatic beta cells to increase insulin release and glucose-dependent insulin secretion.
In addition, blood sugar levels are reduced by reducing the release of glucagon from pancreatic alpha cells and reducing gluco neo genesis and glycogenolysis. Central nervous systemThe mechanism suppresses appetite to reduce calorie intake and weight loss.
Some clinical trials have proved the efficacy of saxoids in inducing significant weight loss of overweight or obese adults and improving metabolic parameters. According to the patient who receives SAXENDA, 56 weeks later, the average of 4.5%of the initial weight was lost, placebo group (p <0.001).
SAXENDA also has been found to improve cardiovascular risk factors such as blood pressure, high density lipoprotein (HDL) cholesterol and triglyceride level. And not only the significant reduction in relaxation blood pressure, but also experienced the improvement of lipid profiles.
Opinion
The US Ambassador and Obesity Surgery Association (ASMBS) recognized SAXENDA as an effective drug for long-term weight management along with lifestyle modifications. We supported the use of GLP-1 receptor agents including de.
Saxenda's Effectiveness in Weight Management
Clinical trial and efficacy
Obesity of scale and prediabetes (scale) test
The scale test was a random, double-blind, placebo control study that assessed the efficacy and safety of the saxure in obese adults with 2,538 overweight or pre-diabetes (5.6-6.1 mmol/L's fast plasma glucose level). The patient who receives a dad has experienced a weight loss (-1.8 kg for-4.5 kg placebo), BMI (-1.7 vs.-0.6) and waist circumference (-6.2 cm vs.-3.0).
Scale maintenance test
The scale maintenance study was an extension of the 68 weeks of the scale test for 1,549 patients who had completed the initial study. It was shown to have experienced a reduction (-2.7 kg).
The Sustain 8 study was a random, double blind, and placebo test that evaluated the efficacy of Saxsonda in the 898 overweight or obese adults with type 2 diabetes (HBA1C 6.0-11.0%).(-3.9 kg placebo), HBA1C level (4.7% ~ 5.8%), and placebo groups have been improved.
Professional authority
Professor John Wilding, a professor of obesity and endocrinology at the University of Liverpool, mentioned Saxenda's efficacy on weight management.
Dr. Arne Astrup, head of nutrition, exercise and sports department at the University of Copenhagen, emphasized the importance of maintaining weight loss with Saxenda."Maintenance research shows that when using Saxenda, the patient can maintain significant weight loss over time. With lifestyle mediation".
Dr. OSAMA HAMDY, a medical officer at the Joslin Diabetes Center, praised the ability to improve blood sugar control for patients with type 2 diabetes."Saxenda Type 2 Diabetes".
Saxenda's Effectiveness and Safety Profile
Expert opinion on efficiency
According to Dr. John B. Dixon, Monash Health's obesity medical expert in Melbourne, Australia, Saxenda has shown practical efficacy in clinical trials associated with overweight and obese adults.: Diet and exercise) experience significant weight loss compared to placebo groups.
Patient compliance and persistence
Dr. Dixon also emphasizes the importance of patient compliance with the recommended daily dose escalation, and emphasizes that the consistent use of Saxenda contributes to better results. Therapy can help patients effectively adapt to this new treatment form.
Combination therapy for improved results
Dr. DIXON points out that some medical workers can prescribe SAXENDA, along with other weight management strategies such as behavioral therapy or anti-anti-drug drugs, to increase the overall effect of the treatment plan.
Safety problems and side effects
The safety profile of Saxenda is extensively evaluated, but like all drugs, potential side effects are provided. Dixon has a symptom of gastrointestinal symptoms (eg, nausea, vomiting, diarrhea)Discussed, he is convinced that these side effects are typically temporary and can often be managed by reducing the dose or adjusting the treatment plan.
Cardiovascular safety
An important concern when treating obesity is cardiovascular safety. Dixon has not increased the main risk of major cardiovascular events in Saxenda's clinical trials, which can be reasonably safe for use in certain patients with existing heart conditions. It suggests.
Long-term impact and maintenance
Dr. DIXON emphasizes the importance of sustained tracking after starting saxenda therapy to ensure long-term success to maintain weight loss. This approach makes medical service providers monitor potential side effects, manage patients' expectations and weightYou can provide continuous support throughout the management journey.
Saxenda for Weight Management
Actual application
In clinical trials, patients using Saxenda showed significant weight loss than placebo groups. In addition to the approved labeling of weight management, Saxenda used off-labels in various actual environments. Some of these applications include:
BARIATRIC SURGERY Preparation: Saxenda is a candidate for obesity but can be prescribed for patients who need to lose weight before additional surgery.
Soldiers and first respondents: weight management is important for the physical strength, preparation and overall health of soldiers and first respondents. Saxenda was used as an accessories of this population life intervention.
Polycystic ovary syndrome (PCOS) management: PCOS patients are often struggling with insulin resistance, obesity and hirsutism. The effects of saxenda on glucose metabolism and weight loss can help improve these symptoms.
When using Saxenda for weight management, the actual patient experience was overwhelmingly positive. Many patients reported that much weight loss, improved blood sugar control and overall health were better. Some of these evaluations are as follows:
Energy level and atmosphere improvement: Patients often have increased energy levels and reduced fatigue while taking saxophones.
Better sleep patterns: Saxenda's weight loss can improve the sleep quality of some patients.
Reduction of insulin requirements: For patients with type 2 diabetes, the weight loss achieved using the saxophone reduced insulin demand.
Professional authority
Some professional authorities support to use Saxenda as an effective tool for weight management and reducing accompanying diseases.
ASMBS (American Society for Metabolic & Bariatric Surgery): ASMBS recognizes the value of weight loss, including SAXENDA, achieves serious weight loss and recognizes the overall health.
National Institute for Health and Care Excellence (NICE): NICE guidelines are recommended to consider Saxenda as a weight management option for BMI ≥ 27 kg/m2 with bmi ≥ 30 kg/m2. With with.
European Obesity Research Association (EASO): EASO approves the use of sax into a part of the integrated approach to obesity management.
Comparing Saxenda to Other Weight Loss Medications
SAXENDA operates by imitating glucagon-like peptide-1 (GLP-1) hormones that control appetite and glucose level. Clinical trials are more effective than placebo for the saxophone inducing significant weight loss. According to a 56-week study, patients treated with SAXENDA have lost an average of 14.9% of weight compared to 2.4% loss of placebo groups. Do it.
Comparison with Penttermin
Pentermine is another drug that is widely used for weight management that acts as an appetite inhibitor. Both drugs can help patients lose weight, but it is more advantageous than Penturine if it shows Saxenda's unique behavior and long-term effects. Saxenda has been shown to improve insulin sensitivity and blood sugar control, which can be particularly favorable for patients with type 2 diabetes.
Safety and tolerability
Saxenda has a relatively advantageous safety profile compared to other weight loss drugs. The most common side effects in clinical trials included nausea, constipation and vomiting, which was resolved over time when the patient adapted to the drug. Unlike Saxenda, there is no risk of increasing blood pressure or heart rate, so it is a safer option for patients with certain cardiovascular conditions.
SAXENDA can improve the effect with other weight loss strategies such as lifestyle interventions and foods and exercise. This flexibility allows medical service providers to adjust the saxoid treatment plan according to the needs and preferences of individual patients.
Long-term data on the efficacy of Saxenda is promising. The patient who continues to use saxenda has maintained weight loss and the average weight loss decreased by 13% at the end of the test. Set Saxenda separately from other weight loss drugs that can show long-term results.
SAXENDA, a one-day daily injection treatment for obesity, is gaining popularity as a weight management option for the patient. Its effect is clear through numerous clinical trials that have shown important results in weight loss (Sanchez et al., 2021) As research on .saxenda continues to develop, there are some potential future development and applications for this drug.
One of the promising development areas of SAXENDA is in the area of personalized medicines. By analyzing individual patient data such as genetics, lifestyle factors and troops, medical service providers can more accurately customize saxophone treatment plans. Is potentially improved efficacy and less side effects (cohen et al., 2021).
Another way of future research is a combination of pigments and weight management strategies. For example, if Saxenda is used alone with behavioral therapy or other drugs, the weight loss results can be much higher. It can help solve potential problems associated with use and recurrence risks (Wing & Phelan, 2021).
It is necessary to take into account the possibility of saxoid as a treatment for such development and other conditions. There is evidence that Liraglutide, an active ingredient of the saxophone, may have an advantage of weight loss, such as improving blood sugar control in type 2 diabetes patients (Vilsbøll et al., 2011). This opens the possibility of using a pigment to treat a wider range of metabolic disorders.
Saxenda has a significant potential as a valuable tool in the fight against obesity. The effect, safety profile and diversity are attractive options for many patients who want to manage weight. Saxenda will continue to play an important role that helps individuals achieve weight loss goals.
Professional authority
Sanchez, M., Navarrete-Pons, J. E., Rueda-Clausen, C. F., & Vidal-Puig, A. (2021). Obesity Management: Lifestyle Change and Pharmaceuticals Options.
Cohen, M. A., Adriaanse, M. C., Van Strien, T., & Blommaert, A. E. L. (2021). Preventing obesity: Self-determination theory.
Wing, R. R., & Phelan, S. (2021). Long-term weight loss .american Journal of Clinical Nutrition, 113, 282S-289S.
(55) 7162 0945
(55) 7162 0913
Customer Service
Home/Workshop Dr. Atl 166, int. 302, cabbage. Santa María la Ribera, Cuauhtémoc, CDMX, CP 06400
Contact us
Sed ut perspiciatis un de omnis iste natus errorae sit voluptatem accusa antium.